Pleural Mesothelioma: 発症,診断,治療,予後,そして生存
1Division of Thoracic Tumor Multimodality Treatment and Department of Medical Oncology Cancer Center West China Hospital Sichuan University Chengdu Sichuan Province China.
MedComm
|September 4, 2025
まとめ
Pleural mesothelioma (PM) の治療は,生存効果が限られており,その後の治療法がないため,課題に直面しています. このレビューは,PM
科学分野:
- 腫瘍学
- 分子生物学
- 免疫学
背景:
- Pleural mesothelioma (PM) は,化学療法や免疫療法などの現在の治療に限られた反応を示し,進行しない生存率 (PFS) と全生存率 (OS) のわずかな改善を示しています.
- 進行後の治療戦略が確立されていないことは,患者の管理に大きな影響を与えます.
- 標的治療の開発の困難は,駆動変異ではなく腫瘍抑制変異によって特徴づけられるPMの遺伝風景に起因する.
研究 の 目的:
- 遺伝的変異,免疫微環境,信号伝達経路を含む,PMの生物学的メカニズムを徹底的に分析する.
- 患者層分化とパーソナライズド医療におけるバイオマーカーの役割を強調する.
- 併用療法や免疫療法などの新しい治療戦略を探求する.
主な方法:
- Pleural mesotheliomaに関する基礎的および臨床的研究の包括的な文献レビュー
- 遺伝子変異,腫瘍の免疫微環境,およびPMにおけるシグナル伝達経路の分析.
- 現在の治療戦略とバイオマーカーの評価
主要な成果:
- PMの病原化には複雑な遺伝的変異, 独特の免疫微環境, 制御不能な信号伝達経路が含まれます
- バイオマーカーは 患者を層分けし 個別化された治療法を作るために不可欠です
- 組み合わせた治療法と新しい免疫療法による介入は 改善の兆しを示しています
結論:
- PMの複雑な生物学を理解することは 治療管理を進めるために不可欠です
- パーソナライズド・メディカルアプローチは バイオマーカーの指針で 患者の治療結果を改善する鍵となります
- PMの治療抵抗性を克服するために,併用および免疫療法を含む新しい治療戦略に関するさらなる研究が必要である.
関連する概念動画
Pleural Disorders: Types and Brief Description
293
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
293
Pleural Effusion II: Symptoms and Management
264
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
264
Pleura of the Lungs
3.1K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
3.1K
Pneumothorax-II
352
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
352
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
269
Endoscopy is a non-surgical medical technique used to examine a person's internal organs and vessels. This lesson will focus on two types of endoscopic studies: bronchoscopy and thoracoscopy.
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...
269
COPD: Pathogenesis and Clinical Features
512
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
512


